[1] Isa&xe, Waal CVD. Are we able to reduce the mortality and morbidity of oral cancer; Some considerations [J]. Medicina Oral Patologia Oral Y CirugiaBucal, 2013, 18(1)∶33-37 [2] Richard V, Sebastian P, Nair MG, et al. Multiple drug resistant, tumorigenic stem-like cells in oral cancer [J]. Cancer Letters, 2013, 338(2)∶300-316 [3] 马壮, 张胜, 朱郁文,等.人舌鳞癌细胞SOCS1基因沉默对细胞增殖和化疗药物敏感性的影响[J].口腔医学研究,2015,31(3)∶283-286 [4] Jiang BH. PI3K/AKT and mTOR/p70S6K1 signaling pathways in human cancer [J]. Current Cancer Drug Targets,2013,13(3)∶233-237 [5] Ni J, Cozzi P, Hao J, et al. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radio resistance via the PI3K/Akt/mTOR signaling pathway [J]. International Journal of Biochemistry & Cell Biology, 2013, 45(12)∶2736-2748 [6] 刘墨,张斌,王安训,等.人舌鳞状细胞癌顺铂耐药细胞发生上皮-间质转化的研究[J].中华口腔医学研究杂志电子版,2014(5)∶5-9 [7] Pan S, Li Z, He Z, et al. Molecular mechanisms for tumor resistance to chemotherapy [J]. Clinical & Experimental Pharmacology & Physiology, 2016, 43(8)∶723-737 [8] Laplante M, Sabatini D M. mTOR signaling in growth control and disease [J]. Cell, 2012, 149(2)∶274-293 [9] Cai Y, Tan X, Liu J, et al. Inhibition of PI3K/Akt/mTOR signaling pathway enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin in vitro [J]. 中国癌症研究(英文版), 2014, 26(5)∶564-572 [10] Vanhaesebroeck B, Vogt PK, Rommel C. PI3K: from the bench to the clinic and back [J]. Current Topics in Microbiology & Immunology, 2010, 347(1)∶1-19 [11] Weichhart T, S emann M D. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications [J]. Annals of the rheumatic diseases, 2008, 67 Suppl 3(6)∶70-74 [12] Wang RC, Wei Y, An Z, et al. Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation [J]. Science, 2012, 338(6109)∶956 [13] Zhang Q, Zhu H, Xu X, et al. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells [J]. Biochemical & Biophysical Research Communications, 2015, 465(1)∶64-70 [14] Peng DJ, Zhou WJY, Wu GS. Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells [J]. Biochemical & Biophysical Research Communications, 2010, 394(3)∶600-605 |